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Anesthetics are widely used in routine aquaculture operations to immobilize animals for 
tagging, spawning, handling, and vaccination. A number of anesthetics are currently available for 
finfish, but their efficacy and optimal dosage is highly species-specific. The efficacy of the 
anesthetic agents (tricaine methanesulfonate (MS-222), clove oil, metomidate, and 2-
phenoxyethanol (2-PE)) was studied in adult, juvenile (133.3 ± 1.5 mm, 27.5 ±  8.9 g), and larval 
Alewives (Alosa pseudoharengus Wilson).  In an initial trial, wild-caught adults were 
anesthetized with doses of 87.5-112.5 mg/L MS-222, 25-40 mg/L clove oil  0.5-5.0 mg/L 
metomidate and 0.125-0.550 mg/L 2-PE. Optimal doses for anesthesia were similar for larvae 
and juveniles, and were identified as: 75-100 mg/L MS-222, 40 mg/L clove oil, 5-7 mg/L 
metomidate, and 500 mg/L 2-PE.  All juvenile fish survived 48 hours post-exposure to each 
optimal dose.  In a longer-term  (24 hour) sedation experiment, juvenile alewives were netted  
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and exposed to low clove oil (2.5 and 5.0 mg/L) and metomidate (0.25 and 0.50 mg/L) doses, 
and plasma cortisol was measured. Fish exposed to the clove oil treatments exhibited a cortisol 
stress response that was prolonged in the higher dose treatment.  No cortisol stress response was 
observed in the metomidate treatments.  Overall, optimal acute anesthesia doses for alewives 










Alewife Life History 
Alewives, Alosa pseudoharengus and blueback herring, Alosa aestivalis, are anadromous 
clupeid fishes found along the Atlantic coast of North America that are collectively referred to as 
river herring in the US and “gaspereau” in Canada (Monroe 2002).  Their natural range is from 
North Carolina to Newfoundland (Scott and Crossman 1988).  They spend the majority of their 
lives at sea but will return to their natal streams and utilize their olfactory sense to guide them to 
their natal rivers.  They are reproductively considered iteroparous, characterized by multiple 
reproductive cycles over the course of its lifetime.  A species is considered semelparous if it has 
a single reproductive episode before death.  Spawning begins between May and June, and adult 
female Alewives (4-5 years old) will spawn between 60,000 and 100,000 eggs in freshwater 
lakes, ponds and streams.  They grow to be 10-11” (25.4-27.9 cm) and ½ pound (0.22 kg) but 
can be as large as 14” (35.6 cm) and a pound (0.45 kg) or more.   
General Species Importance 
Alewives are ecologically important because, as juveniles in riverine environment, they 
serve as prey for several fish species, including large and small mouth bass (Micropterus 
salmoides and Micropterus dolomieu), yellow perch (Perca flavescens), brown trout (Salmo 
trutta) and other salmonids.  Upon entering the estuarine environment, they are preyed upon by 
striped bass (Morone saxatilis), cod (Gadus morhua) as well as numerous birds and mammals, 
and predation increases as they enter the marine environment (Loesch 1987;, Munroe 2002; 
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Walter et al. 2003).  They are an essential keystone species in the freshwater, marine and 
terrestrial food webs. 
Endangered Species 
Historically, river herring were one of the most valuable anadromous fishes harvested 
commercially in New England, and were sold as food, commercial bait, and fertilizer (Belding 
1921; Messieh 1977; Loesch 1987).  River herring populations have been declining in the mid-
Atlantic and Northeast coastal regions for several decades, particularly since the late 1990s. 
Alewives were highly abundant, but as is the case with Atlantic salmon (Salmo salar) and 
many other anadromous fishes, their numbers have declined because of anthropogenic causes, 
including dam construction and overfishing (Savoy and Crecco 1995; Atlantic States Marine 
Fisheries Commission 1999).  According to a technical report published by the Massachusetts 
Division of Marine Fisheries (2011) that assessed river herring stocks, commercial landings 
increased from 5 million pounds in the early 1950’s, to 33 million pounds in 1958.  By the 
early 1980’s, however, river herring landing were only a small percentage of the historical 
highs and regulations in 1989 limited harvest to 25 fish per day.  This coincided with 
restoration programs in the Atlantic states to manage striped bass, an important recreational and 
commercial fishery. 
  The cooperative interstate fishery management of striped bass began in 1981, with the 
development of a fishery management plan by the Atlantic States Marine Fisheries Commission, 
an organization of Atlantic coastal states.  Effective fishery management and additional research 
and monitoring contributed to a tenfold increase in abundance of striped bass stocks by the late 
1990s. This dramatic increase resulted in increased predation on a variety of anadromous fish 
species, including American shad, blueback herring, and Alewives. (Grout 2006).  The decline in 
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river herring is symptomatic of environmental problems that are impacting other fish, wildlife 
and whole ecosystems.  Reasons for their decline include: barriers to fish passage, water 
withdrawals and diversion, loss of habitat, water pollution, poaching and predation.  Fish stocks 
have declined along the east coast from Maryland’s Chesapeake Bay (Fisheries Service 1997) to 
Massachusetts and Maine (Nelson et al. 2011). 
Due to the population decline, several states have placed moratoria on taking or catching 
any river herring (Closed in RI, MA, CT, NC), but a limited harvest is still open in some states, 
including NH and ME.   These states have met sustainable population and spawning criteria 
numbers and habitats to keep regulated fishing open.  Current restoration efforts in New England 
are attempting to reverse this trend by removing dams and constructing fish ladders, to allow 
them to regain access to historical spawning grounds in streams and lakes. 
In 2011, a petition to river herring listing them as endangered was submitted to the 
National Marine Fisheries Service.  In August of 2013 NOAA released an update regarding 
river herring, stating that: “neither species is threatened or endangered so listing under the 
Federal Endangered Species Act is not warranted at this time.  However, we still have concerns 
about the status and threats to these species.  As a result, both species are still included on our 
species of concern list” (NEFSC 2013). One tool that is available for stock enhancement of 
these depleted fish populations is the release of hatchery-reared larvae and juveniles.  
Species Culture 
The earliest documentation of the culture of Alewives in laboratory settings date back to 
the 1950’s and 1960’s and were largely unsuccessful (Mansueti 1956; Norden 1967, 1968).  
Early work with alewife larvae estimated an optimum egg hatching temperature for egg hatching 
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was to be at 18oC (Edsall 1970).  The hatching early growth and feeding of Alewives to day 50 
post-hatch was documented in the early 1980’s (Heinrich 1981).   
Detailed hatchery procedures were not available until a recent study documented 
procedures for spawning, larviculture and established environmental conditions and feeding 
regimes conducive for juvenile growth (DiMaggio et al. 2015).  A very significant aspect of 
culture is the ability to safely handle and transport the fish. Transporting fish to their release sites 
can be stressful, and the addition of salts and buffers and low doses of anesthetics have proven 
useful in reducing stress and improving survival (Tomasso et al. 1980; Mazik et al. 1991; Harrell 
et al. 1992, David and Griffin 2004).  In order to minimize stress and disease, a proper and 
effective anesthetic agent and dose must be determined. 
Anesthetic Use and Function 
 Anesthetics are widely used in routine aquaculture operations to immobilize animals for 
transport, spawning, vaccination and handling.  A fish anesthetic must meet several important 
criteria, such as short induction/recovery time, non-toxicity to fish and humans, no lasting 
physiological effects, rapid clearance from the body, high solubility in fresh and salt water, 
stability under normal hatchery conditions, readily available and cost effective (Schoettger and 
Julin 1967).   Lethal overdoses of an anesthetic may also be used as an ethical way to euthanize 
fish (Stoskopf 1992).  All of the previously mentioned hatchery procedures elicit a defense 
mechanism in the form of a stress response.  All vertebrate organisms attempt to adapt to these 
stresses following the “General Adaptation Syndrome” or GAS (Selye 1950).  This adaptation 
consists of three stages: an alarm reaction, stage of resistance and a stage of exhaustion.  
Following an initial stressor such as netting, handling, or vaccination, the physiological 
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responses may disappear during the stage of resistance, or become exacerbated if the stressor 
continues (Selye 1950). 
Although common physiological responses are universal among vertebrate organisms, the 
fact that fish are poikilothermic and live in an aqueous environment renders them particularly 
sensitive to environmental changes and that elicit stress responses.  When there is a disturbance 
outside the normal (or tolerable) range for that species of fish (e.g. a stessor) a series of 
neuroendocrine responses are initiated and stress hormones are released (catecholamines and 
cortisol).  This primary response initially activates the sympathetic nervous system and causes 
the release of catecholamines  (adrenalin and noradrenalin) from the chromaffin tissue (located 
in the head (anterior) kidney and adrenergic neurons distributed throughout the body.  The 
release of catecholamines from these neurons affect many organ systems, including the 
cardiovascular and respiratory systems, that gives rise to the “fight or flight” response  (Randall 
and Perry 1992).  A stress response also stimulates the hypothalamic-pituitary-interrenal axis 
(HPI axis), that has slower, but longer-acting physiological consequences (Jobling 1995). 
Activation of the HPI axis causes corticotropin releasing hormone, a neuropeptide released from 
the hypothalamus, to stimulate production and secretion of adrenocorticotropic hormone 
(ACTH) from the anterior pituitary gland.  ACTH travels systematically to the head kidney and 
stimulates the production and release of corticosteroid hormones, specifically cortisol.  
The release of catecholamines and cortisol triggers a broad range of biochemical and 
physiological changes that alter a number of metabolic pathways, resulting in profound changes 
to blood chemistry.  One common indictor of secondary (metabolic) response to stressors in 
fishes is an elevated plasma glucose concentration due to cortisol-stimulated glycogen 
catabolism (glycogenolysis).  Increases in plasma glucose concentrations are thought to assist the 
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animal by providing energy substrates to tissues such as the brain, gills and muscles to cope with 
the increased energy demand.  Although adrenaline is cleared rapidly from circulation after 
stress, plasma cortisol and glucose remain elevated for longer periods of time post-stress 
(Vijayan et al. 1996; 1997).  These effects are of particular importance in the period of recovery 
from stress, when the fish attempts to maintain oxygen supplies to tissues and regain osmotic and 
ionic equilibrium.   
Recovery to pre-stress concentrations occurs quickly after removal of a brief or mild 
stressor.  Acute (short term) responses to stressors such as general hatchery handling and other 
anthropogenic activities may be beneficial to the fish and extend their normal adaptive ability 
(Davis 2006).   
In aquaculture, chronic stress, such as that created by poor water quality, predisposes fish 
to a number of diseases resulting from pathogens (viruses, bacteria, fungi and parasites; Walters 
and Plumb 1980; Collins et al. 1976).  In addition to disease and mortality, stress in aquaculture 
situations can reduce growth, thereby reducing profitability or prevent successful reproduction of 
broodstock fish (Noga 2000). Chronic elevation of circulating cortisol is speculated to decrease 
growth by increasing gluconeogenesis (Davis et al. 1985; Barton et al. 1987; Pickering 1990) and 
increase disease susceptibility by suppressing immune function (Maule et al. 1989). 
Use of Anesthetics in Fish Culture 
To minimize many stressors associated with aquaculture, it is common practice to use 
some form of anesthesia.  By definition, anesthesia is a biologically reversible state, induced by a 
chemical or non-chemical external agent, which results in the partial or complete loss of 
sensation or neuromotor control (Summerfield and Smith 1990).  Various anesthetic agents have 
been used with fish since the 1950’s (McFarland 1959; McFarland and Klontz 1969; Schoettger 
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and Julin 1967) and were developed from human and terrestrial veterinary medicine practices.  
Anesthesia (from Greek: an- ‘without’ and aesthesis ‘sensation’) has several levels, but for fish 
culture the primary use is for sedation.  Sedation is a reduction in sensitivity, which results in 
tranquility and calmness, two desirable characteristics for handling fish.  Anesthetic agents are 
now widely used in fish culture, ranging from a light sedation during handling or non-invasive 
procedures to full anesthesia, to avoid inflicting pain during surgery (Ackerman et al. 2005; 
Neiffer and Stamper 2009; Ross and Ross 2008; Summerfelt and Smith 1990).  A generally 
accepted anesthetic is one that produces a total loss of muscular tone within three minutes and a 
recovery time within ten minutes (Maricchiolo and Genovese 2011).  Table 1 illustrates the 
various stages of anaesthesia and their classification according to Zahl et al. (2012).  A broad 
range of anaesthestics are currently available for fish and among the most common are MS-222, 
benzocaine, isoeugenol, metomidate, 2-phenoxyethanal, quinaldine and clove oil (Ackerman et 
al. 2005; Neiffer and Stamper 2009; Ross and Ross 2008; Summerfelt and Smith 1990).  The 
effective dosages of the various anesthesia agents are species-specific and are not well known for 
many of the more than 30,000 fish species (Froese and Pauly 2011).  Additionally, effective 
doses will vary by life stage and environmental conditions (salinity, temperature, pH; Zahl et al. 
2012). A compilation of many anesthetics used in aquaculture and their effective doses are 
provided in Table 2. 
Fish size (weight) is one variable that influences anesthesia dose and induction time, but 
results have been variable among species.   For instance, in Atlantic cod (Gadus morhua), Zahl 
et al. (2009) found greater doses of MS-222 and Benzocaine were required for larger fish and 
this may be due to the relatively smaller gill surface present as fish increase in size (Oikawa and 
Itazawa, 1985).  Similar results were also found for northern pike (Esox lucius) and striped bass 
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(Morone saxatilis) (Dawson and Gilderhus 1979; Gilderhus et al. 1991).  In other species, 
however, such as Atlantic salmon (Olsen et al. 1995), rainbow trout (Oncorhynchus mykiss; 
Gilderhus and Marking 1987) and brook trout (Salvelinus fontilalis; Houston et al. 1976), 
increased efficacy and sensitivity correlated with larger body size. 
 In contrast to size or weight, the effects of temperature are more consistent, with shorter 
induction times at higher water temperatures.  The rapid induction and recovery times associated 
with higher water temperature are likely due to the increases oxygen demand due to increases in 
basal metabolic rates.  This leads to increased respiration and blood flow and accelerated 
absorption and/or elimination of the anesthetics (Zahl et al. 2009).  Recent investigations have 
focused on using combinations of anesthetics to reduce doses (costs) and improve induction and 
recovery efficacy (Zahl et al. 2012).  
Mechanism of Action 
 Numerous anesthetics are commonly used in research including, but not limited to:  
Tricaine methanesulphonate (TMS, MS-222), benzozaine (p-aminobenzoic acid ethyl ester), 
lidocaine {2-(diethylamino)-N-(2,6-dimethylphenyl) acetimide}, metomidate and etomidate {(1-
phenylethyl-1H-imidazole-5-carboxylic acid methyl ester)}, 2-phenoxyethanol (2-PE 1-hydroxy-
2-phenoxyethane), clove oil (Eugenia sp.) and its active ingredients, quinaldine sulfate (2-
methylquinoline sulfate) (Ackerman et al. 2005). For the purpose of this thesis only, those 
chemicals that were tested (MS-222, 2-PE, clove oil and metomidate) will be discussed in detail.  
Appendix Table 3 shows a comparison of anesthetics and their water solubility.  
Globally, very few compounds  (tricaine methanesulfonate, benzocaine, chlorobutanol 
and isoeugenol) have gained approval as fish anesthetics and most have a withdrawal period 
restricting consumption or release of treated animals (Bowker et al 2015).  In the US, MS-222  
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remains the only legally registered anesthetic and has been used extensively for a variety of 
purposes, including immobilization, suppression of sensory systems during invasive procedures, 
and euthanasia (Anderson et al. 1997; Woody et al. 2002; King et al. 2005; Carter et al. 2011).  
MS-222 is one of the most widely used anesthetic drugs in fisheries science worldwide, since its 
introduction as a local analgesic agent in humans in 1967 (Topic Popovic et al. 2012). The use of 
MS-222 in food fish is somewhat limited, however, as extended withdrawal periods are required 
in many countries, post-induction, before human consumption or release into the wild (reviewed 
by Carter et al. 2011; Topic Popovic et al. 2012).  MS-222 has also been used with many fish 
species during laboratory and hatchery procedures.  It is highly water-soluble (1.25 g/mL), 
exhibits rapid uptake via gills, and inhibits the initiation and propagation of action potentials in 
excitable cells.  Therefore, it blocks most neurons and muscle cells and may cause paralysis in 
addition to blocking nociception (Zahl et al. 2012).  The use of MS-222, however, is also 
associated with numerous side effects during prolonged exposure, including hypoxia, elevated 
catecholamine and cortisol levels, and possible effects on P450 enzyme activity in the liver 
(King et al. 2005; Carter et al. 2011; Topic Popovic et al. 2012).  MS-222, therefore, is not 
widely used as a long term sedative, but rather for acute anesthesia induction. 
Clove oil, a distillate of herbaceous portions of the clove tree Eugenia aromatic 
(Webster) has been used for many years as a food additive and a topical analgesic in dentistry.  It 
is recognized as a GRAS (Generally Recognized As Safe) substance by the US Food and Drug 
Administration (FDA) for use in humans, but has not been approved for use with fish in North 
America.  Clove oil or its active ingredient eugenol has been shown to be as effective as MS-222 
for anesthesia in rainbow trout (Anderson et al. 1997).  One mechanism for its analgesic effect is 
the inhibition of prostatglandin H synthase by eugenol (Keene et al. 1998).   
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Another active ingredient in clove oil, isoeugenol, has been commercialized as Aqui-S® 
(50% isoeugenol) and can be used in New Zealand and some other countries without a 
withdrawal period.  Recently, the FDA granted amended authorization (Investigational New 
Animal Drug (INAD) 11-741) for the use of AQUI-S® for the immediate release of freshwater 
finfish sedated as part of field-based fisheries management activities. (USFWS-AADAP). The 
immediate-release provision is for field-use only, and a withdrawal period of 72 hours is still 
required for hatchery use (U.S. Food and Drug Administration 2015). 
Metomidate is a methyl analogue of the imidazole derivate etomidate, which activates 
and modulates inhibitory gamma-aminobutyric acid type A (GABAA) receptors, and thereby 
affects higher regions of the nervous system (Ashton and Wauquier 1985; Yang and Uchida 
1996). Metomidate is classified as a non-barbiturate hypnotic that was developed from the 
mammalian analogue etomidate in the 1960s (Gooding and Corssen 1976; Preziosi and Vacca 
1982: Fraser et al. 1984).  In fishes, one of the effects of metomidate, in addition to respiratory 
and cardiovascular depression, is inhibition of the mitochondrial cytochrome P450 (CYP) 
dependent interenal enzyme 11-β-hydroxylase that catalyzes the production of cortisol from 
deoxycortisol (Wagner et al. 1984; Vanden Bossche et al., 1984).  By preventing cortisol 
synthesis, metomidate mitigates stress responses and has been shown to be superior to other 
anesthetics in many fish species (Mattson and Riple 1989).  It may also be effective in low doses 
for long-term fish transport. 
The final anesthetic chosen for these studies was 2-phenoxyethanol (2-PE), which is 
another commonly used anesthetic agent in fish.  2-PE likely acts to decrease neuron excitability 
in the central nervous system by inhibiting the activity of excitatory N-methyl-D-aspartate 
(NMDA) receptors (Musshoff et al. 1999).  Common 2-PE doses for acute anesthesia range from 
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200 to 600 mg/L, and results in rapid induction and recovery times (Mattson and Riple 1989; 
King et al. 2005). While 2-PE has been widely used in closed recirculating aquaculture systems 
(Velisek et al. 2007), caution should be used at high doses and long exposure times, because of 
the narrow margin between inductive and lethal doses (Ackerman et al. 2005). 
Research Objectives 
The purpose of this research was to establish effective anesthetic doses for use with 
Alewives.  These efforts may improve stock enhancement by mitigating stress during handling 
and transport.  In addition to culturing alewives for stock enhancement, they also offer great 
opportunity as a baitfish to support the lucrative marine recreational fishing industry. Baitfish 
production in the U.S. in 2005 was valued at over $38 million (USDA-NASS 2005).  Current 
production (2013) numbers have declined to $29 million with Arkansas accounting for 62% of 
all U.S. production (Census of Aquaculture 2012).  To date, the production of marine baitfish for 
the enormous recreational fishery in the northeast, including the striped bass (Morone saxatilis) 
fishery have remained untapped.  The striped bass is one of the most sought species by 
recreational anglers, along with the blue fin tuna (Thunnus thynnus) that has gained popularity in 
recent years, as commercial harvests have been limited.  Aquaculture production in the U.S. has 
grown from a $1.1 billion dollar a year industry in 2005 to almost $1.4 billion in 2013, a 21% 
increase (Census of Aquaculture 2012). Advancements in fish husbandry, such as those 
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Stage Plane Description Appearance Swimming 
activity 
Equilibrium Response Respiration 
0  Normal Normal Normal Normal Normal Normal 
I  Light 
sedation 
Disoriented Reduced Normal Slightly 
reduced 
Normal 
II  Excitatory 
Stage 







III 1 Light 
anaesthesia 






 2 Surgical 
anaesthesia 
Anaesthetised Stopped Lost None Shallow 
 3 Deep 
narcosis 
Anaesthetised Stopped Lost None Nearly 
absent 
IV  Impending 
death 
Moribund Stopped Lost None Stopped 
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* Dosage based on a general anesthetic for normal handling.  Size of fish and water quality 
parameters (temperature, salinity and oxygen) will effect dosage. 
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Table 3. Water solubility of anaesthetics. 
 
  Anaesthetic Log P pKa Water Solubility 
(mg/L) 
MS-222 1.8 3.8 1.0 x 105 
Benzocaine 1.9 2.5 1.3 x 103 
Metomidate 
Hydrochloride 
3.1 4.5 6.3 x 10  
2-Phenoxyethanol 1.2 15.1 2.7 x 104 
Isoeugenol 3.0 9.9 3.6 x 102 
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THE USE OF TRICAINE METHANESULFONATE, CLOVE OIL, METOMIDATE,  




The efficacy of the anesthetic agents (tricaine methanesulfonate (MS-222), clove oil, 
metomidate, and 2-phenoxyethanol (2-PE)) was studied in adult, juvenile (133.3 ± 1.5 mm, 27.5 
±  8.9 g), and larval Alewives (Alosa pseudoharengus Wilson).  In an initial trial, wild-caught 
adults were anesthetized with doses of 87.5-112.5 mg/L MS-222, 25-40 mg/L clove oil  0.5-5.0 
mg/L metomidate and 0.125-0.550 mg/L 2-PE. Optimal doses for anesthesia were similar for 
larvae and juveniles, and were identified as: 75-100 mg/L MS-222, 40 mg/L clove oil, 5-7 mg/L 
metomidate, and 500 mg/L 2-PE.  All juvenile fish survived 48 hours post-exposure to each 
optimal dose.  In a longer-term  (24 hour) sedation experiment, juvenile Alewives were netted 
and exposed to low clove oil (2.5 and 5.0 mg/L) and metomidate (0.25 and 0.50 mg/L) doses, 
and plasma cortisol was measured. Fish exposed to the clove oil treatments exhibited a cortisol  
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stress response that was prolonged in the higher dose treatment.  No cortisol stress response was 
observed in the metomidate treatments.  Overall, optimal acute anesthesia doses for alewives 
were similar to those reported for other species, and metomidate may be useful for longer term 
sedation. 
Introduction 
Anesthetics are widely used in routine aquaculture operations to immobilize animals for 
tagging, spawning, handling, and vaccination. These compounds depress the nervous system and 
reduce sensory perception, likely increasing the overall wellbeing of fish during handling 
procedures (Carter et al. 2011; Zahl et al. 2012).  Repeated handling without proper anesthesia 
may induce severe physiological changes, such as a prolonged cortisol response, hyperglycemia, 
and immunosuppression that may ultimately lead to disease, decreased growth or death 
(Wendelaar Bonga 1997; Barton 2002; Carter et al. 2011).  Although MS-222 is currently the 
only fish anesthetic approved for use in food fish in the US, considerable research has been 
conducted on other anesthetics including clove oil and its active ingredients, 2-Phenoxyethanol 
(2-PE), quinaldine and quinaldine sulfate, benzocaine and metomidate (Davis and Griffin 2004; 
King et al. 2005; Weber et al. 2009; Velíšek et al. 2009). 
  The desirable attributes of anaesthetics used for finfish include: short induction and 
recovery time, non-toxicity to fish and humans, no lasting physiological effects, rapid clearance 
from the body, high solubility in fresh and salt water, stable under normal hatchery conditions 
(light, heat), non-foaming, readily available, and cost effective (Schoettger and Julin 1967).  As 
the efficacy and safety of anesthetic agents varies among species, life stages and environmental 
conditions considerable research has been conducted to identify proper anesthetics and their  
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doses, in many commercially important species, including salmonids (Olsen et al. 1995; Woody 
et al. 2002), numerous temperate and cold water marine species (Mattson and Riple 1989, King 
et al. 2005; Weber et al. 2009; Zahl et al. 2009; Zahl et al. 2011), and tropical reef fishes (Cunha 
and Rose 2006).    
 Alewives (Alosa pseudoharengus Wilson) are an anadromous fish found along the north 
Atlantic coast that serve as essential prey for many commercially important piscivorous fish 
species. The range of Alewives extends from Labrador to South Carolina, and often exists 
sympatrically with a congeneric species, Blueback Herring (A. aestivalis Mitchell), that are 
collectively known as river herring (Loesch 1987).  River herring populations have exhibited 
drastic declines throughout much of their range (Hightower et al. 1996) and were listed as U.S. 
National Marine Fisheries Service “species of concern” in 2006.  While the exact causes of these 
population declines are unknown, a number of state-specific fishing restrictions have been 
implemented, including harvest moratoria.  One tool that is available for stock enhancement of 
these depleted fish populations is the release of hatchery-reared larvae and juveniles.  
Transporting fish to their release sites can be stressful, and the addition of salts and buffers and 
low doses of anesthetics have proven useful in reducing stress and improving survival (Tomasso 
et al. 1980; Mazik et al. 1991; Harrell et al. 1992, David and Griffin 2004).  Practical hatchery 
culture methods for both alewives and blueback herring were recently developed (DiMaggio et 
al. 2015), but further research is needed to determine optimal anesthetic agents and their doses 
for handling and transporting these species. 
 The purpose of the present study was to assess effective anesthesia induction and 
recovery in alewives, using four, commonly used anesthetic agents: MS-222, clove oil,  
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metomidate, and 2-phenoxyethanol.  Preliminary trials were conducted with adult alewives, and 
a range of effective doses were further evaluated in larval and juvenile fish.  An additional 
experiment investigated a longer-term (24 hours) exposure of juveniles to low doses of clove oil 
and metomidate, and the cortisol stress response was evaluated.   
Materials and Methods 
Preliminary Adult Trials  
 Adult Alewives (~250 mm total length, 200 g) were collected from Lamprey River fish 
ladders (Newmarket, NH, USA) in May-June 2012 and immediately transported to six, 1,750 L 
tanks within an 11,000 L recirculating system at the University of New Hampshire (UNH) 
Aquaculture Research Center (Durham, NH).  Salinity and water temperature were maintained at 
0 g/L and 15-17°C, respectively, to simulate ambient conditions.  To identify a preliminary range 
of anesthetic doses, individuals (n = 50) were transferred to 20 L containers and subjected by 
bath immersion to various doses of commonly used anesthetic agents.  For all treatments, MS-
222 and metomidate solutions were diluted in freshwater and buffered (pH 7.0-8.0) prior to 
experimental procedures.  In addition, clove oil and 2-PE stock solutions (100 and 500 mg/L, 
respectively) were made using 100% ethanol, prior to dilution with freshwater to appropriate 
concentrations.   
 Following anesthetic administration, individual fish were monitored to observe the 
progress of induction, and timed using a stopwatch.  Anesthetic induction times (seconds, sec) 
were recorded at two stages, following guidelines reviewed by Zahl et al. (2012): 1) the loss of 
equilibrium (Stage III-1), and 2) failure to respond to strong tactile stimuli (Stage III-2).  To  
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evaluate tactile stimulation, fish were removed from the anesthetics, and if no immediate 
reaction occurred, time was recorded and floy tags (Floy Tag, Inc., Seattle, WA) were injected  
into the dorsal musculature using a tagging gun (Mark II Pistol Grip, Avery Dennison 
Corporation, Glendale, CA).  After tagging, fish were placed into new, 20 L containers without 
anesthetic, and timed for progress of recovery to: 1) regain equilibrium (Stage I) and 2) resume 
normal swimming behavior (Stage 0) (Zahl et al. 2012).  
 
Experiment 1: Juvenile Acute Anesthesia 
Based on the effective doses of anesthetics observed in adult preliminary trials, a  dose 
response experiment was conducted using juvenile Alewives.  Juvenile fish (133.3 ± 1.5 mm, 
27.5 ±  8.9 g) were collected by dip net from the outflow of Pawtuckaway Lake (Nottingham, 
NH, USA) in the summer of 2012, and immediately transported to three,  600 L tanks in a 2,000 
L recirculating system at UNH.  Fish were maintained at simulated ambient conditions, fed daily 
rations (Europa 15, 55% protein 15% fat, Skretting, Putten,  Netherlands), and held in culture for 
one month prior to experimental procedures.  Individual fish (n = 5 per treatment) were 
transferred to 3 L plastic tanks that contained various doses of each anesthetic: 1) 62.5, 75.0, 
87.5, or 100 mg/L MS-222, 2) 20.0, 25.0, 30.0, 35.0, or 40.0 mg/L clove oil, 3) 3.0, 4.0, 5.0, 6.0, 
or 7.0 mg/L metomidate, 4) 300.0, 350.0, 400.0, 450.0, or 500.0 mg/L 2-PE.  Progress to 
induction of anesthesia (Stages III-1, -2) was timed as described previously (without tagging), 
and fish were immediately transferred to additional 3 L freshwater tanks and timed for recovery 
(Stages I and 0).  
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To evaluate the effects of anesthetic treatment on juvenile survival, the optimal doses of 
each anesthetic agent (based on shortest Stage III-2 induction and Stage 0 recovery times) were 
used in an additional experiment.  Juvenile Alewives (n = 10 per treatment) were treated with 
each anesthetic dose in 3 L tanks as described above, monitored for progression to Stage III-2, 
and quickly transferred to 300 L freshwater tanks in a 1,400 L recirculating system kept at 
simulated ambient conditions.  The fish were allowed to recover from anesthesia (Stage 0), and 
survival was monitored in the tanks at 24 and 48 hours (hrs).     
 
Experiment 2: Larval Acute Anesthesia 
 To evaluate effective anesthetic doses for larval Alewives, an experiment was conducted 
using the same four anesthetic agents and largely similar concentrations, as described above.  To 
obtain larval fish, previously collected adult female Alewives (n = 28) were selected for 
hormonally-induced spawning, anesthetized in 100.0 mg/L MS-222, and implanted in the dorsal 
musculature with a 95% cholesterol: 5% cellulose pellet (Sherwood et al. 1988) containing 25 µg 
[D-Ala6 Des-Gly10]-LHRH ethylamide (LHRHa; Bachem, Belmont, CA, USA).  After recovery, 
fish were returned to tanks with spermiating males for volitional spawning.  Spawned eggs were 
collected, treated with tannic acid (150 mg/L for 10 min) for disinfection and de-adhesion, and 
incubated at 21-24°C with gentle aeration until hatch (DiMaggio et al. 2015). 
 Larval Alewives were maintained in 80 L static tanks, and kept at 5 g/L salinity with 
simulated natural temperature and photoperiod regimes.  Larvae were fed three times daily S-
strain rotifers (Brachionus plicatilis) and Artemia nauplii from 0-30 and 25-34 days post hatch 
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(DPH), respectively.  At 34 DPH, individual larvae (12.3 ± 0.4 mm, n = 5 per treatment) were 
removed from tanks using plastic containers fitted with a mesh bottom, to avoid water transfer  
that would dilute anesthetic doses.  The plastic containers with larvae were immediately 
submerged into 250 ml beakers containing experimental doses: 1) 37.5, 50.0, 62.5, 75.0, or 87.5 
mg/L MS-222, 2) 20.0, 25.0, 30.0, 35.0, or 40.0 mg/L clove oil, 3) 3.0, 4.0, 5.0, 6.0, or 7.0 mg/L 
metomidate, 4) 300.0, 350.0, 400.0, 450.0, or 500.0 mg/L 2-PE.  Anesthesia induction times 
(Stage III-1, -2) were recorded as described previously, and larvae were gently removed from 
anesthetic treatments using the plastic containers.  Larvae were then transferred to a second 
beaker containing only tank water (5 g/L salinity) to remove excess anesthetic agents, prior to 
submersion in a third beaker for recovery from anesthesia.  Recovery times (Stage I and 0) were 
recorded as described previously.  
Experiment 3: Evaluation of Anesthetic Agents for Sedation 
 The efficacy of two anesthetic agents (clove oil and metomidate) for longer term sedation 
was also evaluated in juvenile Alewives.  Previously collected juvenile fish (174.2 ± 0.1 mm, 
39.5 ± 0.1 g) were quickly netted and removed from recirculating systems and transferred to 
eight, 200 L static tanks (17-18°C, 3 g/L salinity, 24:0 light:dark cycle) that contained four 
replicates of two clove oil concentrations (2.5 or 5.0 mg/L).  Eight to 12 fish were stocked per 
tank, and an additional eight fish were immediately euthanized with 10 mg/L metomidate and 
sampled for plasma cortisol determinations (time = 0 hr).  Briefly, blood was collected from 
caudal vessels using heparinzed syringes, centrifuged at 8,000 x g for 10 min at 4°C, and plasma 
was stored at -20°C.  One hour after transfer to tanks (time = 1 hr), all fish in one static tank from 
each anesthetic concentration were euthanized, and plasma was collected.  This procedure was 
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repeated for the remaining tanks at 3, 6, and 24 hrs.  These experimental procedures were 
conducted two additional times, with 1) two metomidate concentrations (0.25 and 0.50 mg/L), 
and 2) a control experiment without anesthesia. 
 Plasma cortisol levels were measured using a direct enzyme-linked immunosorbent assay 
(ELISA), following protocols adapted from the Smithsonian’s National Zoological Park 
endocrine workbook (Brown et al. 2013).  Briefly, plasma samples (50 µl) were double extracted 
using 1.0 ml diethyl ether, dried at 37°C under a constant stream of N2, stored at -20°C, and 
reconstituted in 0.15-1.2 ml assay buffer (0.1 M phosphate, 0.15 M NaCl, 0.1% bovine serum 
albumin, pH 7.0).  NUNC 96-well Maxisorp plates (Thermo Fisher Scientific, Inc., Waltham, 
MA) were coated with 1:8500 diluted rabbit anti-cortisol antibody (University of California, 
Davis, CA) and incubated overnight at 4°C.  Plates were washed with 0.15 M NaCl and 0.05% 
Tween 20 in a microplate washer (Thermo Labsystems, OPSYS MW, Thermo Fisher Scientific) 
and blotted dry.  Samples, cortisol standards (0.078-20 ng/ml, Sigma Aldrich), and cortisol-
horseradish peroxidase conjugate (University of California Davis) were added and incubated for 
1 hr at room temperature.  Plates were washed again, incubated with substrate buffer (0.05 M 
citric acid, 6.0 mM H2O2, 0.4 mM 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid), pH 
4.0) for 15 min with shaking, and absorbance was read at 405 and 620 nm using a Synergy 2 
Plate Reader (BioTek, Winooski, VT).  Background absorbance (620 nm) was subtracted from 
405 nm readings prior to analyses, and cortisol standard curves were generated using a 5 
parameter logistic model in GEN 5 software (BioTek).  Cortisol assays were also validated for 
parallelism using blood plasma pooled from >20 individuals, and assay quality was monitored 
using duplicate pool samples included on each plate.  Intra- and interassay coefficients of 
variation for cortisol assays were 3.0 ± 0.7 and 12.5 ± 0.6 %, respectively.             
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Statistical Analysis 
 One-way analysis of variance (ANOVA) followed by Tukey’s post hoc tests for multiple 
comparisons (JMP Pro 11, SAS Institute, Cary, NC, USA) were used to identify differences 
among anesthetic doses.  Some data (anesthesia induction/recovery time, plasma cortisol 
concentrations) were either log or square root transformed prior to analyses to meet normality 
and equal variance assumptions.  All data are represented as the mean ± standard error, and P < 
0.05 was considered statistically significant for all analyses.   
 
Results 
Preliminary Adult Trials 
 Most adult Alewives anesthetized with low MS-222 doses (87.5 or 100.0 mg/L) exhibited 
extended Stage-III-2 induction and Stage 0 recovery times (~ 600 and 840 sec, respectively).  
The highest MS-222 dose (112.5 mg/L), however, effectively anesthetized all fish (n = 12, mean 
341 ± 14 and 644 ± 43 sec).  Similarly, the lowest clove oil (25.0 mg/L), metomidate (0.5 mg/L), 
and 2-PE (0.125 mg/L) doses were not effective anesthetics and resulted in strong responses to 
tactile stimulation (>600 sec).  Rather, higher doses (35.0, 5.0, and 550.0 mg/L, respectively) 
exhibited rapid induction and recovery times, with 2-PE overall being a very rapid anesthetic 
agent for adults (n = 4, Stage III-2: 210 ± 4; Stage 0: 315 ± 27 sec). 
Experiment 1: Juvenile Acute Anesthesia  
 Juvenile Alewives largely exhibited faster induction times with increasing concentration 
of each anesthetic agent (Table 4).  The lowest doses of MS-222 (62.5 mg/L), clove oil (20.0 
mg/L), and 2-PE (300.0 mg/L) were ineffective at inducing anesthesia in some fish (n = 2, 1, and 
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5, respectively).  In contrast, recovery times were similar among most doses within an anesthetic 
treatment, with Stage I times exhibiting no significant differences.  Stage 0 recovery times,  
however, exhibited significant increases in the MS-222, clove oil, and 2-PE higher doses.  Based 
on the fastest Stage-III induction and Stage 0 recovery times, the optimal doses for each 
anesthetic agent for juveniles were: 100.0 mg/L MS-222, 40.0 mg/L clove oil, 5.0 mg/L 
metomidate, and 500.0 mg/L 2-PE.  Higher optimal metomidate concentrations were not chosen 
due to the extremely high mean Stage 0 recovery time for 6.0 mg/L (696 ± 63 sec).  Optimal 
anesthetic doses resulted in 100% survival in all treatments at 24 and 48 hrs post acute exposure. 
Experiment 2: Larval Acute Anesthesia  
 Larval Alewives exhibited faster induction times with increasing concentration of each 
anesthetic agent (Table 5).  All doses were effective at inducing anesthesia.  Recovery times 
generally decreased or remained stable with increasing concentration, except among MS-222 
doses, where the highest dose (87.5 mg/L) resulted in significantly longer Stage I recovery.  The 
optimal doses for each anesthetic agent for larvae were: 75.0 mg/L MS-222, 40.0 mg/L clove oil, 
7.0 mg/L metomidate, and 500.0 mg/L 2-PE.  The highest MS-222 concentration was not chosen 
as optimal due to the elevated mean Stage I recovery time (138 ± 14 sec).     
Experiment 3: Evaluation of Anesthetic Agents for Sedation 
 Juveniles exposed to longer term (24 hr) doses of either clove oil or metomidate exhibited 
different plasma cortisol profiles (Fig. 1).  Control fish that were not immersed an anesthetic 
agent exhibited peak cortisol levels at 3 hr post handling, followed by a return to basal levels by 
6 hr.  In contrast, fish exposed to 2.5 mg/L clove oil exhibited peak cortisol at 1 hr, then a 
decrease at 3 hr (Fig. 1A).  Juveniles in the 5.0 mg/L clove oil treatment also exhibited an 
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increase and decrease in plasma cortisol levels at 1 and 3 hrs, respectively, but was followed by 
gradual increases at 6 and 24 hrs.  One individual in this treatment also exhibited extremely high 
cortisol levels at 24 hrs, and was above the assay’s detectable limit (>504 ng/ml plasma).   
 Metomidate concentrations (0.25 and 0.5 mg/L), in comparison to the control, induced 
little increase in plasma cortisol concentration by 3 hrs (40 and 14 ng/ml, respectively), and  
remained near basal levels throughout the experiment (Fig. 1B).  Among the anesthetic 
treatments, both metomidate concentrations also resulted in significantly lower plasma cortisol 
than either clove oil dose at 1 hr (P < 0.0001).  At 3 hrs post handling, the 0.5 mg/L metomidate 
dose exhibited significantly lower cortisol than the other treatments (P < 0.0001).  At 6 and 24 
hrs, the 2.5 mg/L clove oil and 0.25 mg/L metomidate exhibited similarly low cortisol levels, 
while the 5.0 mg/L clove oil treatment was significantly elevated (P < 0.0001).  The 0.50 mg/L 





 Many biological and environmental factors, including stage of life cycle, size, water 
temperature, lipid content, and age can influence the metabolic rates of fishes, and therefore the 
pharmokinetics of anesthetic compounds to which they are exposed (Zahl et al. 2011).  Members 
of the genus Alosa have been shown to be highly susceptible to stressors that can lead to high 
mortality rates during hatchery practices (Mylonas et al.  1995). In the present study, Alewives 
were effectively anesthetized using acute doses of four, commonly used anesthetic agents.  
Optimal doses of MS-222, clove oil, metomidate, and 2-PE were largely similar among larvae, 
juveniles, and adult fish, and were also similar to doses used in other species, including Black  
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Sea Bass (Centropristis striata), Atlantic Cod (Gadus morhua), Red Pacu (Piaractus 
brachypomus), salmonids, Senegalese Sole (Solea senegalensis), and many tropical reef species 
(Mattson and Riple 1989; Sladky et al. 2001; Woody et al. 2002; King et al. 2005; Roubach et al. 
2005; Cunha and Rose 2006; Weber et al. 2009; Carter et al. 2011).  Although no mortality was 
evident in juveniles 48 hrs after exposure to each optimal dose, longer term sedation with clove 
oil did elicit a prolonged cortisol response.  Since some of these commonly used chemicals  
exhibit different modes of action, the choice of induction method in Alewives, as in other 
species, is dependent on several factors, including the invasiveness of the procedure, length of 
anesthetic exposure, cost and legal authorization. 
 MS-222 has been one of the most widely used anesthetic drugs in fisheries science 
worldwide, since its introduction as a local analgesic agent in humans in 1967 (Topic Popovic et 
al. 2012).  It remains the only legally approved anesthetic for use in fish in the United States and 
Canada, and has been used extensively for a variety of purposes, including immobilization, 
suppression of sensory systems during surgical procedures, euthanasia, as well as many 
laboratory and hatchery procedures (Anderson et al. 1997; Woody et al. 2002; Carter et al. 
2011).  The use of MS-222 in food fish is somewhat limited, however, as extended withdrawal 
periods are required in many countries, post-induction, before human consumption or release 
into the wild (reviewed by Carter et al. 2011; Topic Popovic et al. 2012). It is water soluble, 
rapidly crosses the gill membrane, and suppresses neural transmission in both the peripheral and 
central nervous systems (Carter et al. 2011).  A range of adverse effects are also associated with 
the use of MS-222, however, including hypoxia, elevated catecholamine and cortisol levels, 
depression of cardiovascular, osmoregulatory and respiratory function and possible effects on  
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hepatic P450 enzyme activity (Carter et al. 2011; Topic Popovic et al. 2012; Zahl et al. 2012).  
MS-222, therefore, is not recommended for prolonged sedation, but rather for acute anesthesia 
induction (Carter et al. 2011).  In the present study, short term MS-222 exposure was highly 
effective in Alewives, at similar doses (75-112.5 mg/L) to those reported in numerous other 
teleosts, including salmonids and marine species (Sladky et al. 2001; Woody et al. 2002; King et 
al. 2005; Zahl et al. 2011).  2-PE is a colorless, oily liquid compound with antibacterial 
properties that is found in many dermatological products, perfumes, and insect repellent.  It is 
also used as an anesthetic agent in fish, although the exact mechanism of action has not been 
reported (Zahl et al. 2012).  Common 2-PE doses for acute anesthesia range from 200 to 800 
mg/L, and result in rapid induction and recovery times (Mattson and Riple 1989; King et al. 
2005; Weber et al. 2009; Mitjana et al. 2014).  Adverse effects of 2-PE are similar to those 
reported for MS-222 and include reduced cardiovascular function, elevated cortisol levels, and 
immunosuppression (Iwama et al. 1989; Mattson and Riple 1989; Ortuño et al. 2002).  All 
Alewives, irrespective of age, were effectively anesthetized at approximately 500 mg/L, and no 
negative impacts were observed on larval fish.  For both larval and juvenile Alewives, the 
highest 2-PE dose tested (>500 mg/L) resulted in the most rapid anesthesia induction, but 
recovery at the higher doses (400-500 mg/L) was dose independent. Whereas both positive 
(Mitjana et al. 2014) and negative (Weber et al. 2009) dose-dependent recovery times have been 
reported, further research, exploring higher doses of 2-PE is warranted for Alewives.  
 Clove oil, derived from the Eugenia aromaticum tree, and its active ingredients eugenol 
and iso- eugenol, are other widely used fish anesthetics (Javahery et al. 2012; Zahl et al. 2012).  
Clove oil was historically used as a human dental analgesic and has been affirmed as a Generally  
	  33	  
Recognized as Safe (GRAS) substance that can be used in human alimentation by the US Food 
and Drug Administration (FDA; Gullian and Villanueva 2009).  Despite this fact, clove oil and 
its active ingredients are not approved as a fish anesthetics in the US, but iso-euganol, marketed 
as Aqui-S®, is approved for use in food fish in Australia, New Zealand, Costa Rica, Republic of 
Korea and Chile with no withdrawal period (Zahl et al. 2012).  Clove oil is relatively inexpensive 
and has been shown to be highly effective in many freshwater and marine species (Cho and 
Heath 2000; Javahery et al. 2012).  Determination of species-specific dosages is imperative, 
however, to avoid potentially severe adverse effects (Barton and Helfrich 1981; Sladky et al. 
2001; Woody et al. 2002; Hill and Forster 2004; Woolsey et al. 2004; Javahery et al. 2012). 
 In the present study, total recovery times for juvenile Alewives were prolonged compared 
to MS-222 and 2-PE, and in larvae were greater than all the other anesthetics tested.  Extended 
recovery from clove oil may be due to the persistence of oil on gill surfaces, which likely 
increases exposure times (Sladky et al. 2001).  Clove oil has been shown to cause local 
inflammation and cellular necrosis (Sladky et al. 2001) and elevates cortisol levels in the absence 
of other stressors (Zahl et al. 2010).   In the present study, fish quickly transferred to tanks 
containing clove oil at low doses (2.5 and 5.0 mg/L) experienced a cortisol stress response, 
similar to that of the controls.  This suggests a need for pre-anesthetic sedation prior to transfer to 
mitigate the transfer stress.  Juvenile fish exposed to the higher clove oil dose for a prolonged 
period (24 h) experienced a second cortisol elevation, which may have been due to a stress 
response elicited by tissue irritation.          
 Metomidate is a water-soluable, rapid-acting, non-barbituate hypnotic that has proven to 
be highly effective for immobilizing many fish species (Mattson and Riple 1989; Davis and  
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Griffin 2004; Zahl et al. 2012; Iversen et al. 2013).  Metomidate has also been shown to block 
cortisol synthesis, prevent handling-related glucose elevation, and perhaps prevent the 
immunosuppressive effects cortisol has been shown to induce (Maule et al. 1989; Barton and 
Iwama 1991; Thomas and Robertson 1991, Olsen et al. 1995; Sandodden et al. 2001).  It has 
been suggested that because of these properties, metomidate in low concentrations may be useful 
for mitigating the stress effects associated with fish transport (David and Griffin 2004).  In the 
present study, Alewives anesthetized with metomidate underwent rapid induction, but the 
recovery of juveniles was somewhat longer than that required for the other anesthetics tested.  
Unlike the fish transferred to tanks containing low does of clove oil, however, those exposed to 
low metomidate concentrations for prolonged periods did not experience a cortisol stress 
response.  Metomidate, therefore may be useful for alewife transfer to release sites, but will 
require regulatory clearance prior to adoption.   
 In summary, all of the anesthetic agents tested were effective for acute anesthesia in 
larval, juvenile, and adult Alewives with induction and recovery times similar to those found in 
many other teleost species. Prolonged exposure to low doses of clove oil, but not metomidate 
resulted in elevated cortisol levels.  Further research is necessary to determine the effects of 
environmental conditions (e.g. temperature and salinity) on anaesthesia efficacy as well the 
benefits of pre-anesthetic sedation prior to netting and transport.  
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Table 4. Induction and recovery times (sec) of juvenile Alewives (Alosa pseudoharengus 
Wilson) exposed to various doses (mg/L) of anesthetics (treatment).  Stages of anesthesia refer to 
those defined by Zahl et al. 2012, and sample sizes are indicated by n.  Different letters denote 
significant differences among doses within one anesthetic treatment.  Bolded text indicates the 
recommended optimal dose for each anesthetic.  The 300.0 mg/L 2-PE treatment was removed 
from analyses due to poor efficacy to induce anesthesia. 
Treatment 
Dose 
(mg/L) n Stage III-1 
(sec) 
Stage III-2 





MS-222 62.5 3 292 ± 19z 691 ± 81z  73 ± 5 236 ± 2zy 
 75.0 5 252 ± 57z 389 ± 29y  158 ± 34 273 ± 20z 
 87.5 5 137 ± 20zy 231 ± 12x  82 ± 12 174 ± 15y 
 100.0 5 69 ± 8y 149 ± 19x  95 ± 15 197 ± 12y 
Clove oil 20.0 4 177 ± 25z 417 ± 43z  250 ± 28 430 ± 22z 
 25.0 5 91 ± 20y 285 ± 30zy  225 ± 34 318 ± 20zy 
 30.0 5 60 ± 3yx 207 ± 23yx  262 ± 39 364 ± 32zy 
 35.0 5 44 ± 2x 166 ± 16x  238 ± 43 371 ± 31zy 
 40.0 5 54 ± 3yx 143 ± 10x  197 ± 22 310 ± 22y 
Metomidate 3.0 5 103 ± 12z 554 ± 47z  424 ± 54 664 ± 76 
 4.0 5 50 ± 4y 237 ± 16y  299 ± 58 480 ± 66 
 5.0 5 44 ± 4yx 142 ± 9y  340 ± 51 542 ± 51 
 6.0 5 31 ± 3x 224 ± 56y  478 ± 88 696 ± 63 
 7.0 5 34 ± 6yx 145 ± 11y  262 ± 29 473 ± 41 
2-PE 350.0 5 68 ± 7 452 ± 71z  252 ± 80 363 ± 56z 
 400.0 5 67 ± 9 181 ± 26y  122 ± 17 214 ± 12y 
 450.0 5 68 ± 9 153 ± 7y  105 ± 22 216 ± 16y 
  500.0 5 38 ± 4 107 ± 5y   96 ± 16 214 ± 23y 
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Table 5.  Induction and recovery times (sec) of larval Alewives (Alosa pseudoharengus Wilson) 
exposed to various doses (mg/L) of anesthetics (treatment).  Stages of anesthesia refer to those 
defined by Zahl et al. 2012, and sample sizes are indicated by n.  Different letters denote 
significant differences among doses within one anesthetic treatment.  Bolded text indicates the 
recommended optimal dose for each anesthetic. 
Treatment 
Dose 
(mg/L) n Stage III-1 
(sec) 
Stage III-2 





MS-222 37.5 5 115 ± 3z 334 ± 42z  87 ± 8y 218 ± 9zy 
 50.0 5 94 ± 11z 214 ± 15zy  85 ± 9y 251 ± 25z 
 62.5 5 53 ± 8y 144 ± 21yx  76 ± 13y 155 ± 18y 
 75.0 5 47 ± 9y 119 ± 16xw  95 ± 8zy 169 ± 5y 
 87.5 5 30 ± 4y 82 ± 6w  138 ± 14z 206 ± 13zy 
Clove oil 20.0 5 141 ± 11z 355 ± 26z  112 ± 10 254 ± 32 
 25.0 5 136 ± 17z 329 ± 42z  127 ± 53 266 ± 56 
 30.0 5 68 ± 12y 175 ± 12y  121 ± 25 278 ± 19 
 35.0 5 58 ± 8y 147 ± 6y  151 ± 23 288 ± 32 
 40.0 5 47 ± 9y 100 ± 12x  106 ± 14 253 ± 24 
Metomidate 3.0 5 113 ± 22z 487 ± 82z  61 ± 14 413 ± 27z 
 4.0 5 121 ± 19z 325 ± 78zy  86 ± 26 298 ± 28zy 
 5.0 5 64 ± 11zy 182 ± 31yx  94 ± 27 285 ± 53zy 
 6.0 5 44 ± 3y 158 ± 19x  148 ± 29 276 ± 49zy 
 7.0 5 50 ± 11y 156 ± 17x  84 ± 15 184 ± 14y 
2-PE 300.0 5 105 ± 7z 281 ± 52z  32 ± 5 127 ± 14 
 350.0 5 58 ± 6y 209 ± 23zy  45 ± 5 115 ± 13 
 400.0 5 53 ± 8y 170 ± 27zy  60 ± 11 138 ± 16 
 450.0 5 63 ± 13y 183 ± 19zy  57 ± 11 136 ± 14 
  500.0 5 42 ± 5y 124 ± 23y   57 ± 16 134 ± 21 
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Fig. 1. Plasma cortisol levels ± standard error (ng/ml) of juvenile Alewives (Alosa 
pseudoharengus Wilson) exposed to an acute handling stressor, followed by 24 hr doses of clove 
oil (A) and metomidate (B).  The control curve refers to fish exposed to the stressor but without 
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CONCLUSIONS AND FUTURE DIRECTIONS 
 
 In summary, all of the anesthetic agents tested were effective for acute anesthesia in 
larval, juvenile, and adult Alewives, with induction and recovery times similar to those found in 
many other teleost species. Prolonged exposure to low doses of clove oil, but not metomidate, 
resulted in elevated cortisol levels.  Further research is necessary to determine the effects of 
environmental conditions (e.g. temperature and salinity) on anesthesia efficacy as well the 
benefits of pre-anesthetic sedation prior to netting and transport.  The literature cited indicates 
that temperature will have the most significant effect on the doses and recovery times due to the 
direct effect on the metabolic rate of poikilothermic species (Zahl et al. 2012).  Combined 
anesthetic and temperature toxicity and increased efficacy could be measured at various 
temperatures now that suitable dosages have been determined for alewives. 
 The majority of hatchery management procedures, including sampling, grading, 
transferring and transportation, are often time consuming and result in cortisol stress responses in 
fish. As both restocking and baitfish production require handling and transportation, methods for 
reducing stress are imperative to improve long- term survival.  Although continued research is 
required, these initial findings show metomidate to be a very useful anesthetic because it inhibits 
the cortisol stress response.  Because metomidate is relatively expensive, however, future 
investigations may include using metomidate in combination with other anesthetics to reduce 
costs while still mitigating stressors. 
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Metomidate may be useful for Alewife transfer to release sites, but its widespread use 
will require regulatory approval prior to adoption.  The fisheries and aquaculture professions 
would benefit greatly from greater to FDA-approved drugs.  The lack of approved anesthetics for 
fish use is due to several factors, including complexities in the approval process, and the 
substantial human and monetary resources necessary for adequate testing (Bowker et al. 2015).  
In the United States, sufficient data must be developed to demonstrate the effectiveness and 
safety of any drug on an animal before it can gain approval.  In the specialized case of fish, this 
process requires generation of acceptable data in studies with two representative cold, cool, and 
warm-water fishes (personal communication, David Erdahl, U.S. Fish and Wildlife Service, 
Boseman, Montana).  Attempting to obtain approval within the current framework will require 
substantial resources, both public and private, and may take years to complete (Trushenski et al. 
2012a, b, c, d).  Early reports suggest new aquaculture drug claims require a minimum 
investment of $3.5 million dollars (Schnick et al. 1996) over a ten-year period.  Recent estimates 
indicate that figure may exceed $40 million, depending on the claim (Storey 2012).   
Once approved for use, another aspect important to any hatchery is cost.  This is a 
reoccurring operating expense and depending on the size of the hatchery could be very costly.  
Table 4 shows a comparison of prices of fish anesthetics from commercial sources (Sigma 
Aldrich Co. LLC and Western Chemical Inc.). Prices vary due to quantities purchased so several 
cost/quantity are shown.  Clove oil and 2-phenoxyethanol would have the lowest cost per dose 
based on determinations in this study ($0.18 and $0.47) respectively, whereas MS-222 and 
metomidate are at $1 per dose or more depending on purchase quantities.  Ultimately, the choice 
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of anesthesia used in a hatchery should be based on overall efficacy including long-term benefits 
to the fish’s well being, as well as relative costs.   

































APPENDIX A: ANIMAL CARE AND USE APPROVAL DOCUMENTATION 
 
